Assessment of tumor response, AFP response, and time to progression in the phase 3 CELESTIAL trial of cabozantinib versus placebo in advanced hepatocellular carcinoma (HCC) Meeting Abstract
| Authors: | Merle, P.; Rimassa, L.; Ryoo, B.; Cicin, I.; Harris, W.; Banu, E.; Sarker, D.; Tan, B.; Van Vlierberghe, H.; Sen, S.; Love, C.; Cheng, A.; Meyer, T.; Kelley, R.; Abou-Alfa, G. |
| Abstract Title: | Assessment of tumor response, AFP response, and time to progression in the phase 3 CELESTIAL trial of cabozantinib versus placebo in advanced hepatocellular carcinoma (HCC) |
| Meeting Title: | ESMO 20th World Congress on Gastrointestinal Cancer |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2018 Jun 20-23 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-06-01 |
| Start Page: | mdy149.010 |
| Language: | English |
| ACCESSION: | WOS:000439970900011 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy149.010 |
| Notes: | Meeting Abstract: O-011 -- Appears on page v104 of the abstract book -- Source: Wos |
